Stay updated on Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial page.

Latest updates to the Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial page
- Check7 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site as revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe study record history now shows a new revision entry 'Revision: v3.7.0'. The previous revision 'Revision: v3.6.6' is removed from view, updating the versioning state of the record.SummaryDifference0.0%

- Check48 days agoChange DetectedVersion 89 shows the study as Completed with updated Study Status and Recruitment Status fields, replacing the previous Active, not recruiting status from the prior revision.SummaryDifference0.3%

- Check70 days agoChange DetectedThe page footer now shows Revision: v3.6.5, replacing the prior v3.6.4. This reflects a system release rather than a modification to the study data or its history.SummaryDifference0.0%

- Check84 days agoChange DetectedThe footer revision label updated from v3.6.3 to v3.6.4, indicating a new site release. This update does not modify study content or user-facing functionality beyond the version tag.SummaryDifference0.0%

- Check106 days agoChange DetectedThe page footer shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This reflects a version update and does not change the study details or results.SummaryDifference0.0%

Stay in the know with updates to Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial page.